Alaunos Therapeutics, Inc. Additional Paid in Capital, Common Stock
Alaunos Therapeutics, Inc. (TCRT) had Additional Paid in Capital, Common Stock of $927.23 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-14
- 2026-06-30: Additional Paid in Capital, Common Stock $927.23M.
- 2026-03-31: Additional Paid in Capital, Common Stock $926.91M.
- 2025-12-31: Additional Paid in Capital, Common Stock $926.77M.
- 2025-09-30: Additional Paid in Capital, Common Stock $926.53M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $927.23M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $926.91M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $926.77M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $926.53M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $926.23M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $922.58M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $922.51M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $922.43M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $922.35M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $922.23M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $922.07M 10-K · filed 2025-03-31 | $922.06M 10-K · filed 2024-04-01 |
| 2023-09-30 | $921.58M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $920.86M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $919.94M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $919.17M 10-K · filed 2024-04-01 | $918.94M 10-K · filed 2023-03-07 |
| 2022-09-30 | $903.37M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $902.54M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $901.55M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $900.69M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $899.55M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $896.39M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $891.08M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $887.87M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $886.03M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $884.21M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $882.54M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $778.95M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $774.32M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $656.22M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $653.82M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $651.73M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $604.65M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $609.25M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $613.30M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $615.49M 10-K · filed 2019-03-05 | |
| 2017-09-30 | $619.23M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $622.05M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $578.57M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $580.57M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $582.23M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $583.80M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $582.40M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $579.94M 10-K · filed 2017-02-16 | |
| 2015-09-30 | $576.93M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $575.36M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $571.32M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $406.35M 10-K · filed 2016-02-24 | |
| 2014-09-30 | $398.58M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $390.19M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $388.57M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $386.51M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $331.82M 10-Q · filed 2013-10-22 | |
| 2013-06-30 | $330.74M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $327.50M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $325.18M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $305.54M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $304.22M 10-Q/A · filed 2012-08-28 | |
| 2012-03-31 | $302.60M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $246.52M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $244.67M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $243.81M 10-Q/A · filed 2011-08-09 | |
| 2010-12-31 | $131.53M 10-K · filed 2012-02-29 | |
| 2010-09-30 | $131.28M 10-Q · filed 2011-08-01 | |
| 2009-12-31 | $96.13M 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |